Interní Med. 2012; 14(3): 129-131

Rational examinations indication in patients with arterial hypertension

MUDr.Eva Kociánová, MUDr.Jan Václavík, Ph.D., doc.MUDr.Miloš Táborský, CSc., FESC, MBA
I. interní klinika &ndash, kardiologická, Fakultní nemocnice Olomouc

The paper presents a practical view on indicating basic and complementary examinations in a patient with arterial hypertension that

are the cornerstone for determining cardiovascular risk, degree of organ damage and suspicion for an identifiable secondary cause of

hypertension.

Keywords: hypertension, subclinical organ damage, secondary hypertension

Published: March 26, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kociánová E, Václavík J, Táborský M. Rational examinations indication in patients with arterial hypertension. Interní Med. 2012;14(3):129-131.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cífková R, Škodová Z, Bruthans J, et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertens. 2010; 28(11): 2196-2203. Go to original source... Go to PubMed...
    2. Sinclair A, Isles C, Brown I, et al. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147: 1289-1293. Go to original source...
    3. Widimský J, jr., Cifková R, Špinar J, et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze Cor Vasa 2008; 50(1): K5-K22.
    4. de Jong WH, Eisenhofer G, Post WJ, et al. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. J Clin Endocrinol Metab. 2009; 94(8): 2841-2849. Go to original source... Go to PubMed...
    5. Lenders JW, Willemsen JJ, Eisenhofer G, et al. Is supine rest necessary before blood sampling for plasma metanephrines? Clin Chem. 2007; 53(2): 352-354. Go to original source... Go to PubMed...
    6. Streeten D, Tomycz N, Anderson G. Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 1979; 67: 403-413. Go to original source... Go to PubMed...
    7. Funder JW, Carey RM, Fardella C, et al. Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008; 93(9): 3266-3281. Go to original source... Go to PubMed...
    8. Gordon R. Primary aldosteronism. J Endocrinol Invest 1995; 18: 495-511. Go to original source... Go to PubMed...
    9. Štejfa M. Kardiologie. Praha Grada 2007: 542.
    10. Sawka AM, Gafni A, Thanabe L, Young WF. The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocr Metab 2004; 89: 2859-2866. Go to original source... Go to PubMed...
    11. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005; 165: 1147-1152. Go to original source... Go to PubMed...
    12. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am. J. Kidney Dis., 1999, 33: 1004-1010. Go to original source... Go to PubMed...
    13. Tesař V, Zima T, Racek J, et al. Doporučení České nefrologické společnosti a České společnosti klinické biochemie ČLS JEP k vyšetřování proteinurie. In: http://www.cskb.cz/res/file/doporuceni/dop-proteinurie.pdf.
    14. Kaye TB, Crapol. The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 1990; 112(6): 434-444. Go to original source... Go to PubMed...
    15. Hodgkinson J, Mant J, Martin U, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011; 342: d3621. Go to original source... Go to PubMed...
    16. Cuspidi C, Lonati L, Macca G, et al. Cardiovascular risk stratification in hypertensive patients: impact of echocardiography and carotid ultrasonography. J Hypertens 2001; 19: 375. Go to original source... Go to PubMed...
    17. Sehestedt T, Jeppesen J, Hansen TW, et al. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? J Hypertens 2009; 27: 1165. Go to original source... Go to PubMed...
    18. Anderson G, Blakeman N, Streeten D. Prediction of renovascular hypertension. Am J Hypertens 1988; 1: 301-304. Go to original source... Go to PubMed...
    19. Lee H, Grant EG, Sonography in Renovascular Hypertension. J Ultrasound med 2002; 21: 431-441. Go to original source... Go to PubMed...
    20. Berglund AS, Hulthen UL, Manhem P, et al. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice: primary and secondary evaluation for localization of phaeochromocytomas. J Intern Med 2001; 249: 247-251. Go to original source... Go to PubMed...
    21. Nieto F, Young T, Lind B, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000; 283: 1829-1836. Go to original source... Go to PubMed...
    22. Silverberg DS, Iaina A and Oksenberg A. Treating Obstructive Sleep Apnea Improves Essential Hypertension and Quality of Life. American Family Physician 2002; 65(2): 229-236. PMID 11820487. Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.